Adverse Reaction to Drug Completed Phase 2 Trials for Propofol (DB00818)

IndicationStatusPhase
DBCOND0042486 (Adverse Reaction to Drug)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01621373Exploratory Propofol Dose Finding Study In NeonatesTreatment